Physician profile
Mona Hassan
NPI 1366720666
$1,033.72
in general payments reported to CMS, 2019-2025
12 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $45.58 · 2021: $83.20 · 2022: $16.32 · 2023: $196 · 2024: $242 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.75 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $301.20 | 2020-2025 | |
| Abbvie INC. | $200.40 | 2019-2025 | |
| Allergan, INC. | $120.27 | 2019 | |
| Intercept Pharmaceuticals, INC. | $112.80 | 2019-2020 | |
| Exelixis INC. | $69.99 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.39 | 2021-2025 | Entyvio, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.17 | 2024-2025 | Xifaxan |
| Ipsen Biopharmaceuticals, INC | $37.53 | 2024-2025 | Iqirvo |
| Echosens North America, INC. | $24.68 | 2024 | Fibroscan |
| Janssen Biotech, INC. | $24.19 | 2024 | Stelara |
| Mallinckrodt Hospital Products INC. | $22.96 | 2025 | Terlivaz |
| Shire North American Group INC | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Hassan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.